TAK-041
CAS: 1929519-13-0
Ref. 3D-ECD51913
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
TAK-041 is an analog of a protein that acts as an anticancer agent by inhibiting cyclin-dependent kinases (CDKs). This inhibitor has been shown to be effective against various types of cancer cells, including those derived from human urine and Chinese hamster ovary cells. TAK-041 induces apoptosis in cancer cells by inhibiting the activity of CDKs, which are involved in cell cycle regulation. The inhibition of these kinases leads to cell cycle arrest and ultimately cell death. TAK-041 is a promising candidate for the development of new anticancer drugs and may have potential as a targeted therapy for a variety of tumors.
Chemical properties
Technical inquiry about: 3D-ECD51913 TAK-041
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
